Details
Tirzepatide (10mg) – Dual GIP/GLP-1 Receptor Agonist
Advance laboratory analysis with Tirzepatide, a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Supplied exclusively for educational, empirical, and in-vitro research applications, Tirzepatide is widely evaluated in laboratory settings investigating dual incretin signaling, metabolic pathway interactions, and cell-receptor kinetics.
Research Properties & Applications
Key Research Properties:
- Dual Incretin Pathway Activation: Evaluated for simultaneous affinity at GIP and GLP-1 receptor sites.
- Metabolic Pathway Modeling: Investigated in cellular models studying lipid dynamics and metabolic signaling.
- Receptor Affinity Analysis: Utilized in laboratory assays examining glycemic control mechanisms and glucagon modulation.
- High Purity Standard: Independently 3rd-party tested to guarantee exact sequence integrity and chemical purity.
Ideal For:
- In-vitro dual incretin receptor research
- Comparative metabolic pathway analysis
- Receptor binding and signaling kinetics modeling
- Cellular energy balance and peptide interaction studies
Laboratory Reference Protocol
Standard empirical research assays utilize benchmark concentrations ranging from 2.5 mg to 15 mg per test subject/model interval. Specific working concentrations depend on experimental protocol objectives.
Reconstitution Guidance
Add 1mL of sterile bacteriostatic water to achieve a working concentration of 10mg/mL (where 0.1mL / 10 units on a standard syringe equals 1mg of Tirzepatide).
Storage & Compliance Disclaimer
Storage: Store lyophilized powder in a cool, dark environment away from direct light. Once reconstituted, store under refrigeration between 2°C – 8°C (36°F – 46°F) and use within 30 days.
Disclaimer: This product is sold strictly as a laboratory research chemical and is not intended for human or animal consumption, medical, diagnostic, or therapeutic use.
